Administering

Managing problems when using transdermal patches

9 July 2025Guidance on adhesion, skin reactions, missing, omitted or delayed application, dosing intervals, switching, accidental exposure, and MRI scan considerations.

Using transdermal patches safely in healthcare settings

9 July 2025Practical guidance for safe application, monitoring, removal, disposal, documentation and storage of transdermal patches to reduce risk of medication errors.

Risk assessment of preparation of monoclonal antibodies

27 June 2025A systematic approach to occupational risk assessment informs decisions about safe working practices with monoclonal antibodies (mAb)

Occupational exposure to monoclonal antibodies

27 June 2025Understanding potential exposure to monoclonal antibodies (mAb) informs the occupational risk assessment

Safe handling of monoclonal antibodies

27 June 2025Considerations for occupational safety when preparing monoclonal antibodies (mAb)

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Considerations for using medicines following bariatric surgery

30 May 2025Guidance on the physiological changes after bariatric surgery that can affect the pharmacokinetics of medicines and supplements.

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Offender healthcare settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings